VERU 240920 1.50C (VERU240920C1500) Stock Options, News & Quotes

0.02
0.000.00%

15min DelayTrading Sep 9 10:45 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Trytosaveabit

Aug 8 05:34

Make a note! Only ifn you want? Didn’t mean to order you to do something you may not want to? Hehehe

$Veru Inc (VERU.US)$ Veru Inc: Topline Data for Primary Endpoint of Lean Body Mass Expected January 2025

Trytosaveabit

Jun 24 07:40

Update

$Veru Inc (VERU.US)$ Veru Presents Phase 2 and 3 Enobosarm Data At ADA Scientific Sessions: Well-Tolerated With Comparable Adverse Event Profile To Placebo; Effective In Reducing Fat And Preserving Lean Mass In Older Adults And Cancer Patients

seb240sx

May 29 21:20

$Veru Inc (VERU.US)$ what happen ? bad news ?

seb240sx

May 9 14:49

insider buyer 🤟

$Veru Inc (VERU.US)$ 376 000 share acquire by STEINER MITCHELL SHUSTER
and 102 000 share to FISCH HARRY

Sean Parker

May 8 06:07

news

$Veru Inc (VERU.US)$
Veru Reports Fiscal 2024 Second Quarter Financial Results and
Progress of its Enobosarm High Quality Weight Loss Clinical Program
—Phase 2b clinical study of enobosarm in combination with semaglutide (Wegovy®*) for highquality weight loss is actively enrolling—
—Company assembles esteemed high quality weight loss Scientific Advisory Board – five MDswith significant relevant medical, clinical and scientific expertise—
—Company to present this month at upcoming American Ass...